Literature DB >> 5129323

Urinary excretion of pregnanetriol and 5 -pregnenetriol in two forms of congenital adrenal hyperplasia.

A M Bongiovanni, W R Eberlein, T Moshang.   

Abstract

Although congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase deficiency generally reveals a predominance of Delta(5)-3beta-hydroxysteroids, on occasion substantial quantities of pregnanetriol have been found as well. It appears that the latter steroid more often occurs in the subjects who have survived beyond infancy. The use of the measurement of pregnanetriol alone may therefore not be relied upon as a sole determinant of the specific form of defective steroidal biogenesis. It is more characteristic of the 21-hydroxylase deficiency. However when both Delta(5)-pregnenetriol and pregnanetriol are measured the ratio of the former to the latter is always considerably below 1.0 in 21-hydroxylase deficiency and always above 1.0 in 3beta-hydroxysteroid dehydrogenase. Furthermore, 11-ketopregnanetriol has been found only in the urine of subjects with the 21-hydroxylase deficiency. Thus, these two forms of defective steroidal biogenesis may be distinguished by the measurement of these three urinary steroidal metabolites.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5129323      PMCID: PMC292226          DOI: 10.1172/JCI106777

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  7 in total

1.  Further studies on the origin of pregnanetriol in adrenal carcinoma.

Authors:  D K FUKUSHIMA; H L BRADLOW; L HELLMAN; T F GALLAGHER
Journal:  J Clin Endocrinol Metab       Date:  1963-03       Impact factor: 5.958

2.  The adrenogenital syndrome with deficiency of 3 beta-hydroxysteroid dehydrogenase.

Authors:  A M BONGIOVANNI
Journal:  J Clin Invest       Date:  1962-11       Impact factor: 14.808

3.  Origin of pregnanetriol in a patient with adrenal carcinoma.

Authors:  D K FUKUSHIMA; H L BRADLOW; L HELLMAN; T F GALLAGHER
Journal:  J Clin Endocrinol Metab       Date:  1962-08       Impact factor: 5.958

4.  An investigation of the possible precursors of urinary pregnanetriol.

Authors:  K FOTHERBY; D N LOVE
Journal:  J Endocrinol       Date:  1960-09       Impact factor: 4.286

5.  17alpha-Hydroxypregnenolone as a precursor of urinary steroids in a patient with a virilizing adenoma of the adrenal.

Authors:  K D ROBERTS; R L VANDE WIELE; S LIEBERMAN
Journal:  J Clin Endocrinol Metab       Date:  1961-12       Impact factor: 5.958

6.  Unusual type of congenital adrenal hyperplasia probably due to deficiency of 3-beta-hydroxysteroid dehydrogenase. Case report of a surviving girl and steroid studies.

Authors:  M Zachmann; J A Vollmin; G Murset; H C Curtius; A Prader
Journal:  J Clin Endocrinol Metab       Date:  1970-06       Impact factor: 5.958

7.  Plasma and urinary steroids in an eight-year-old boy with 3-beta-hydxysteroid dehydrogenase deficiency.

Authors:  O Jänne; J Perheentupa; R Vihko
Journal:  J Clin Endocrinol Metab       Date:  1970-08       Impact factor: 5.958

  7 in total
  4 in total

1.  Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia.

Authors:  G Schneider; M Genel; A M Bongiovanni; A S Goldman; R L Rosenfield
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

2.  Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency.

Authors:  M Zachmann
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

Review 3.  Endocrine findings in male pseudohermaphroditism.

Authors:  M Zachmann
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

4.  Urinary excretion delta 5-pregnenetriol (5-pregnene-3 beta, 17 alpha, 20-triol) in healthy children.

Authors:  W M Teller; B Raue; S B Pal
Journal:  Eur J Pediatr       Date:  1980-08       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.